Concepedia

In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension

Bethany R. Baumgart, Mausumee Guha, James K. Hennan, Julia Li, Jochen Woicke, Damir Simic, Michael J. Graziano, Nicola Wallis, Thomas P. Sanderson, Roderick T. Bunch

Cancer Chemotherapy and Pharmacology · 2017 · 15 citations · 26 references

DOI

Concepts

References

26

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Nazzareno Galiè, Marius M. Hoeper, Marc Humbert et al. · European Heart Journal · 2009 · 3.9K citations · Full text

, , +11

Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

Lucien Abenhaim, Yola Moride, François Brenot et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

, , +9

Reversal of experimental pulmonary hypertension by PDGF inhibition

Ralph T. Schermuly · Journal of Clinical Investigation · 2005 · 1.1K citations · Full text

, , +16

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Uwe Rix, Oliver Hantschel, Gerhard Dürnberger et al. · Blood · 2007 · 663 citations · Full text

, , +17

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

David Montani, Emmanuel Bergot, Sven Günther et al. · Circulation · 2012 · 650 citations · Full text

, , +11